Skip to content
Open access

ПЕРСОНАЛИЗИРОВАННАЯ ОЦЕНКА РИСКА ТЯЖЁЛЫХ ФОРМ ВАРИКОЗНОЙ БОЛЕЗНИ ВЕН НИЖНИХ КОНЕЧНОСТЕЙ НА ОСНОВЕ БИОХИМИЧЕСКИХ И ГЕНЕТИЧЕСКИХ ПОКАЗАТЕЛЕЙ

2026 · Avicenna Bulletin · 0 citations · 16 references

Abstract

Background: Varicose veins of the lower extremities (VVLE) is a chronic, progressive disorder of the venous system. It can lead to chronic venous insufficiency and trophic disorders, which significantly impair a patient's quality of life. Despite extensive research on individual biochemical and genetic factors, integrated prognostic models for personalized risk assessment of severe forms of the disease remain lacking. Objective: To evaluate biochemical and genetic factors associated with severe forms of VVLE (classes C4-C6 according to the CEAP classification) to develop a personalized risk stratification approach. Methods: This observational comparative study included 371 patients with VVLE. Of these, 187 patients had clinical classes C2-C3, and 184 had classes C4-C6. All patients underwent duplex ultrasound scanning of the lower extremity veins. Peripheral venous blood levels of E-selectin, MCP-1, MMP-2, VEGF, and MMP-9 were determined using an enzyme-linked immunosorbent assay (ELISA). Genotyping of 13 single-nucleotide polymorphisms was performed using real-time PCR. Results: Patients with severe disease were significantly older and had higher levels of all studied biochemical markers (p<0.001). Independent predictors for the development of classes C4-C6 were patient age, the levels of MMP-9 (OR=1.248), MMP-2 (OR=1.015), and VEGF (OR=1.016), as well as the genetic polymorphisms VEGFA rs2010963, MMP2 rs243865, and COL1A1 rs1800012. The combined predictive model demonstrated high discriminatory ability (AUC=0.91) with a sensitivity of 81% and a specificity of 88%. Conclusion: The developed model enables personalized risk assessment of varicose vein progression. It can identify patients at high risk of developing severe forms of the disease early. Keywords: Varicose veins, chronic venous insufficiency, biochemical markers, genetic polymorphisms, risk prediction.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.